Devon Park Bioventures, based in Wayne, Pennsylvania, is a venture capital firm specializing in investments in the life sciences sector. Founded in 2006, the company focuses on identifying and supporting innovative companies involved in therapeutics, medical devices, diagnostics, and drug discovery technologies. With its strategic location in the Philadelphia metropolitan area, Devon Park Bioventures is well-positioned to engage with a multitude of leading organizations in the healthcare and biotechnology fields. The firm is dedicated to fostering advancements that can enhance patient care and drive growth in the life sciences industry.
Vascular Magnetics, Inc. is a company focused on developing a novel therapy known as Vascular Magnetic Intervention (VMI) for peripheral artery disease (PAD), a prevalent condition that causes obstruction of the arteries in the legs. VMI employs a magnetic targeting catheter that generates a uniform magnetic field around the leg, combined with biodegradable magnetic particles that deliver a drug designed to prevent artery re-obstruction. This innovative approach serves multiple purposes: it enhances the implantation of new stents by ensuring effective drug delivery to the arterial wall, allows for the re-treatment of previously implanted stents that have become restenosed, and provides a treatment option for arteries that do not require stenting. Established in 2010, Vascular Magnetics is headquartered in Philadelphia, Pennsylvania.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.